or Try an Advanced Search...

    Technical Analysis for ENTX - Entera Bio Ltd.

    Grade Last Price % Change Price Change
    B 2.42 -1.22% -0.03
    ENTX closed down 0.81 percent on Wednesday, May 8, 2024, on 44 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical ENTX trend table...
    Date Alert Name Type % Chg
    Stochastic Reached Overbought Strength -1.22%
    Inside Day Range Contraction -1.22%
    Wide Bands Range Expansion -1.22%
    Overbought Stochastic Strength -1.22%
    MACD Bullish Signal Line Cross Bullish -2.02%
    Wide Bands Range Expansion -2.02%
    Gapped Up Strength -2.02%
    Up 3 Days in a Row Strength -2.02%
    Up 4 Days in a Row Strength -2.02%
    Up 5 Days in a Row Strength -2.02%
    Older End-of-Day Signals for ENTX ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 1 hour ago
    Rose Above Previous Day's High about 5 hours ago
    Down 2 % about 5 hours ago
    Down 1% about 5 hours ago
    Up 2% about 5 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ENTX Chart by TradingView
    Basic chart:

    Profile

    Entera Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for use in orphan indications and other areas with significant unmet medical need. The Company is initially applying its technology to develop an oral formulation of parathyroid hormone (PTH) for hypoparathyroidism (EB612) and osteoporosis (EB613).
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Endocrine System Hormones Thyroid Osteoporosis Molecule Therapeutics Glands Hypoparathyroidism Parathyroid Hormone

    Is ENTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 26 Entera Bio Ltd. (ENTX) Stock Slides as Market Rises: Facts to Know Before You Trade
    Apr 18 Why the Market Dipped But Entera Bio Ltd. (ENTX) Gained Today
    Apr 12 Is Entera Bio (ENTX) Outperforming Other Medical Stocks This Year?
    Apr 9 Here's Why You Should Invest in Entera Bio (ENTX) Stock Now
    Apr 8 Entera Bio Announces Publication of Oral PTH(1-34) Peptide Tablets (EB613) Phase 2 Trial Data in the Journal of Bone and Mineral Research
    Mar 24 12 Best Biotech Penny Stocks to Invest In
    Mar 23 We Think Entera Bio (NASDAQ:ENTX) Can Afford To Drive Business Growth
    Mar 20 Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome
    Mar 8 Entera Bio GAAP EPS of -$0.31 beats by $0.01
    Mar 8 Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates
    See more ENTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.35
    52 Week Low 0.52
    Average Volume 297,917
    200-Day Moving Average 1.02
    50-Day Moving Average 1.86
    20-Day Moving Average 2.24
    10-Day Moving Average 2.15
    Average True Range 0.25
    RSI (14) 62.69
    ADX 31.09
    +DI 30.55
    -DI 14.34
    Chandelier Exit (Long, 3 ATRs) 2.61
    Chandelier Exit (Short, 3 ATRs) 2.55
    Upper Bollinger Bands 2.77
    Lower Bollinger Band 1.71
    Percent B (%b) 0.7
    BandWidth 47.22
    MACD Line 0.12
    MACD Signal Line 0.11
    MACD Histogram 0.0124
    Fundamentals Value
    Market Cap 86.92 Million
    Num Shares 35.5 Million
    EPS -0.34
    Price-to-Earnings (P/E) Ratio -7.21
    Price-to-Sales 2280.62
    Price-to-Book 5.12
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.66
    Resistance 3 (R3) 2.64 2.56 2.63
    Resistance 2 (R2) 2.56 2.50 2.57 2.61
    Resistance 1 (R1) 2.50 2.47 2.53 2.52 2.60
    Pivot Point 2.42 2.42 2.43 2.43 2.42
    Support 1 (S1) 2.36 2.36 2.39 2.38 2.30
    Support 2 (S2) 2.28 2.33 2.29 2.29
    Support 3 (S3) 2.22 2.28 2.28
    Support 4 (S4) 2.24